STipe Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- STipe Therapeutics's estimated annual revenue is currently $5.3M per year.
- STipe Therapeutics's estimated revenue per employee is $155,000
Employee Data
- STipe Therapeutics has 34 Employees.
- STipe Therapeutics grew their employee count by 6% last year.
STipe Therapeutics's People
| Name | Title | Email/Phone |
|---|
STipe Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is STipe Therapeutics?
STipe Therapeutics is a privately held biotechnology company with a vision to become a leader in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The Company was spun out from Aarhus University, Denmark in 2018 and concluded a EUR 20 million a Series A financing in September 2019.
keywords:N/A
N/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Denmark
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5M | 35 | 3% | N/A |
#2 | $9.2M | 36 | -55% | N/A |
#3 | $5M | 39 | 34% | N/A |
#4 | $6.7M | 40 | -5% | N/A |
#5 | $6.5M | 45 | 18% | N/A |